AU2144899A - Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use - Google Patents

Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use

Info

Publication number
AU2144899A
AU2144899A AU21448/99A AU2144899A AU2144899A AU 2144899 A AU2144899 A AU 2144899A AU 21448/99 A AU21448/99 A AU 21448/99A AU 2144899 A AU2144899 A AU 2144899A AU 2144899 A AU2144899 A AU 2144899A
Authority
AU
Australia
Prior art keywords
polymerizing
viral vectors
vectors expressing
intermediate filaments
neuronal intermediate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21448/99A
Inventor
Claude Gravel
Jean-Pierre Julien
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JEAN PIERRE JULIEN
Original Assignee
JEAN PIERRE JULIEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JEAN PIERRE JULIEN filed Critical JEAN PIERRE JULIEN
Publication of AU2144899A publication Critical patent/AU2144899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU21448/99A 1998-01-13 1999-01-13 Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use Abandoned AU2144899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2220847 1998-01-13
CA2220847 1998-01-13
PCT/CA1999/000007 WO1999036559A1 (en) 1998-01-13 1999-01-13 Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use

Publications (1)

Publication Number Publication Date
AU2144899A true AU2144899A (en) 1999-08-02

Family

ID=4161757

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21448/99A Abandoned AU2144899A (en) 1998-01-13 1999-01-13 Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use

Country Status (2)

Country Link
AU (1) AU2144899A (en)
WO (1) WO1999036559A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012103343A1 (en) * 2011-01-28 2012-08-02 The Board Of Trustees Of The Leland Stanford Junior University Functional targeted brain endoskeletonization
US10545075B2 (en) 2012-08-09 2020-01-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for preparing biological specimens for microscopic analysis
CA2947898A1 (en) 2014-05-30 2015-12-03 The Board Of Trustees Of The Leland Stanford Junior University Methods and devices for imaging large intact tissue samples
WO2017139501A1 (en) 2016-02-10 2017-08-17 The Board Of Trustees Of The Leland Stanford Junior University Rna fixation and detection in clarity-based hydrogel tissue

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008026A1 (en) * 1992-09-25 1994-04-14 Rhone-Poulenc Rorer S.A. Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, particularly in brain

Also Published As

Publication number Publication date
WO1999036559A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
HUP9801139A3 (en) Polysiloxane-polyol macromers, their preparation and their use
EP0710667B8 (en) Modified oligonucleotides, their preparation and their use
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
EP1032377A4 (en) Substituted 2-aminoacetamides and the use thereof
IL128882A0 (en) Viral vectors and their uses
AU6503299A (en) High-beta-conglycinin products and their use
AU8828598A (en) Retrovirus and viral vectors
AU7525298A (en) Surface-modified, oxidic or silicated filling materials and the use thereof
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
SI1141308T1 (en) Group b streptococcus proteins, and their use
AU4261999A (en) Direct hair dye and the use thereof
GB9816761D0 (en) Herpesvirus preparations and their uses
AU2619797A (en) Silyl-linked polyamidoamines and their preparation
AU3695297A (en) Alfa-amino acid amides, preparation thereof and the therapeutical use thereof
AU7495796A (en) Novel oligopeptides, the preparation and use thereof
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
AU6962698A (en) Transgenomic viruses and the use thereof
AU2144899A (en) Viral vectors expressing self-polymerizing neuronal intermediate filaments and their use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
HUP0104723A3 (en) New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use
AU5557698A (en) Novel calpaines, their preparation and use
PL351027A1 (en) Outer surface proteins, their genes, and their use
HUP0102988A3 (en) Peroxides, their preparation process and use
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
NZ330551A (en) 2-aryloxy-6-aryl-3,5-difluoropyridines, their use as herbicides and their preparation thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase